Intangible Assets and Goodwill

9 Months Ended

Sep. 30, 2016

Goodwill And Intangible Assets Disclosure [Abstract]

Note 6 – Intangible Assets and Goodwill

Identifiable intangible assets

The Company’s identifiable intangible assets are associated with its acquisitions of HGP in 2012 and NLEX in 2014, as shown in the table below (in thousands), and are amortized using the straight-line method over their estimated useful lives of two to twelve years. The Company’s trade name, acquired as part of the acquisition of NLEX in 2014, has an indefinite life and therefore is not amortized.

	Carrying Value					Carrying Value
Amortized Intangible Assets	December 31, 2015		Amortization			September 30, 2016
Customer Network (HGP)	$	178	$	(17	)	$	161
Trade Name (HGP)		1,059		(78	)		981
Customer Relationships (NLEX)		660		(82	)		578
Non-Compete Agreement (NLEX)		15		(15	)		—
Website (NLEX)		33		(7	)		26
Total		1,945		(199	)		1,746

Unamortized Intangible Assets
Trade Name (NLEX)		2,437		—			2,437
Total	$	4,382	$	(199	)	$	4,183

Amortization expense during the first nine months of 2016 and 2015 was $0.2 million and $0.5 million, respectively.

The estimated amortization expense as of September 30, 2016 during the remainder of the current fiscal year, the next four fiscal years, and thereafter is shown below (in thousands):

Year	Amount
2016 (remainder of year from October 1, 2016 to December 31, 2016)	$	61
2017		245
2018		245
2019		240
2020		236
Thereafter		719
Total	$	1,746

Goodwill

The Company’s goodwill is related to its asset liquidation business, and is comprised of goodwill from three acquisitions, as shown in the table below (in thousands). There were no impairment losses or other charges to the carrying amount of goodwill during the nine months ended September 30, 2016 and 2015.

Acquisition	September 30, 2016		December 31, 2015
Equity Partners	$	573	$	573
HGP		2,040		2,040
NLEX		3,545		3,545
Total goodwill	$	6,158	$	6,158

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details